Imc Chicago, LLC Harrow Health, Inc. Transaction History
Imc Chicago, LLC
- $2.35 Billion
- Q1 2025
A detailed history of Imc Chicago, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Imc Chicago, LLC holds 37,523 shares of HROW stock, worth $917,437. This represents 0.04% of its overall portfolio holdings.
Number of Shares
37,523Holding current value
$917,437% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
186Shares Held
21MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$97.6 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$52.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$45.8 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$41.4 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$22.2 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $662M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...